(Total Views: 717)
Posted On: 03/30/2022 6:56:42 PM
Post# of 145879
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Interim analyses at 40% of enrollment are 245 for moderate and 126 for critical (larger total and subgroups than the totals for CD12).
Four doses in Brazilian trials , four IV for critical.versus 2 doses SQ in CD12.
Interim analysis could easily yield statistical significance along with the known clinical significance.
Let’s go Leron!
Four doses in Brazilian trials , four IV for critical.versus 2 doses SQ in CD12.
Interim analysis could easily yield statistical significance along with the known clinical significance.
Let’s go Leron!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)